A Safety, Efficacy and Tolerability Study of SEP-225289

Clinical trial NCT00584974 · COMPLETED

Trial details

NCT number: NCT00584974
Sponsor: Sumitomo Pharma America, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Depressive Disorder, Major

Start date: 2007-12-01
Primary completion: 2009-05-01
Enrollment: 523

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.